These Are The World’s Largest Drug And Biotech Companies

in the first quarter thanks to higher demand. It pulled in $20.7 billion in sales last quarter for profits of $2.30 per share. In an earnings release, the company said that sales of consumer products like Tylenol and Zyrtec rose nearly 10% as consumers stocked up on over-the-counter drugs to reduce fever and other symptoms associated with COVID-19.

Johnson & Johnson, which has a market cap of $387 billion, announced in March that it has chosen a leading vaccine candidate for the virus; it anticipates starting human trials by September of this year. Chief scientific officer Paul Stoffels told ABC’s “The Week” that the company is aiming to deliver

Я верю в лучшее

Drug pushers. Yrumps beloved Dow needs speculative hype

How awesome that some companies are making huge monies on this COVID19 thingy... 🤑

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

PNC Financial to Exit Full Investment in BlackRockBlackRock's largest shareholder, PNC Financial, is exiting its roughly 22% stake in the firm, ending a lucrative wager on the world’s largest money manager Obvious. I may be stating the obvious, but announcing a huge sale at this uncertain time has a hint of desperation about it, compared with an offer to purchase. davidmwessel Unfolding. Let’s see the post sale impact on institutional vs non institutional in near to mid term horizon.
مصدر: WSJ - 🏆 98. / 63 اقرأ أكثر »